[Value of pharmacokinetic data during the treatment of psychoses with haloperidol].
Pharmacokinetic data of psychotropic drugs should allow a better understanding of therapeutic results and side effects. The different factors influencing liberation, absorption, protein binding, distribution, metabolism and excretion are reviewed. Then, the principal pharmacokinetic data of haloperidol are exposed with a special emphasis on the lack of information about the correlations between plasma levels and clinical effects. The role of pharmacokinetic informations in the interpretation of responses to treatment is detailed, wishing that the monitoring of haloperidol plasma levels will be more developped in a next future.
D006220:Haloperidol / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D011618:Psychotic Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000378:metabolism; D014018:Tissue Distribution
D011619:Psychotropic Drugs; D006220:Haloperidol
Intérêt des données pharmacocinétiques au cours des traitements des psychoses par l'halopéridol.